Drug overdose deaths continue to rise: Experts predict little resolve for years to come

Smoke-Fentanyl-LA

Important Takeaways:

  • U.S. drug overdose deaths hit a record in 2022 as some states see a big surge
  • Drug deaths nationwide hit a new record in 2022. 109,680 people died as the fentanyl crisis continued to deepen, according to preliminary data released by the Centers for Disease Control and Prevention.
  • Eight states saw drug deaths continue to surge by nine percent or more, with the greatest increases of 21 percent coming in Washington state and Wyoming.
  • Nora Volkow, director of the National Institute on Drug Abuse, said it’s troubling that deaths continue to rise despite the end of disruptions linked to the COVID pandemic.
  • “That’s a very, very high level of overdose deaths,” Volkow told NPR.
  • “One could have expected that as many of the challenges imposed by the COVID pandemic were resolved, we would see a deep dive in the number of overdose deaths. It’s concerning we have not seen that.”
  • A major study from the medical journal the Lancet last year predicted opioid-fentanyl drug deaths will remain high, claiming another 1.2 million lives in the U.S. by the end of this decade.
  • “I am not particularly optimistic for the future,” said Jonathan Caulkins, an addiction policy researcher at Carnegie Mellon University.
  • “We have multiple millions of people with opioid use disorder and that’s not something you can simply make go away. We are as a country in for bad times for years to come.”
  • Volkow, head of NIDA, suggested major policy changes could begin to reduce opioid-fentanyl deaths, but she acknowledged progress has been slow.

Read the original article by clicking here.

After decriminalizing hard drugs Portland becomes an open air market for drugs

Romans 1:21-22,24 “Because, although they knew God, they did not glorify Him or give thanks to Him as God, but became futile in their imaginations, and their foolish hearts were darkened. 22 Claiming to be wise, they became fools.  24 Therefore God gave them up to uncleanness through the lusts of their hearts, to dishonor their own bodies among themselves.

Important Takeaways:

  • Portland resembles an ‘open air drug market’ after decriminalizing hard drugs: Overdose deaths skyrocket by 41% in the Democrat-led city as homeless addicts collapse on sidewalks
  • Law enforcement agents say that the streets of Portland are full of homeless addicts openly buying and selling drugs
  • Photos show the desperate situation in the Pacific Northwest city, where people can be seen shooting up drugs or passed out in broad daylight
  • The dreadful scene comes 16 months after Ballot Measure 110 went into effect in February 2021
  • Oregon was the first state in the United States to decriminalize possession of personal-use amounts of heroin, methamphetamine, LSD, oxycodone
  • But since the measure was passed overdose deaths in the state hit an all-time high in 2021 with 1069, a 41 percent increase from 2020

Read the original article by clicking here.

Fentanyl the leading cause of overdose deaths. Making up 64%

2 Thessalonians 2:11 “Therefore God sends them a strong delusion, so that they may believe what is false”

Important Takeaways:

  • Drug overdose deaths up again in Virginia in 2021, fentanyl the leading cause
  • Virginia saw an overall 15% increase in drug overdose deaths from 2020 to 2021
  • The fourth-quarter report shows 2,656 total overdose deaths in 2021, a 15% increase from 2020. Synthetic fentanyl was reported as contributing to the most deaths, with 2,033 deaths recorded. Cocaine proved the second most common contributor to drug overdoses in Virginia in 2021, with 801 deaths reported versus the 650 reported in 2020.
  • The CDC reported a 28.5% increase in overall drug overdoses from 2020 to 2021. Opioid overdoses also saw a nearly 26% increase from 2020 to 2021 nationally, with 75,673 total opioid overdose deaths reported in 2021, according to the CDC.
  • “Fentanyl and fentanyl related substances are fueling the overdose epidemic, killing 64,178 Americans between May 2020 and April 2021 and making up 64% of total U.S. overdose deaths,” the letter said.
  • Approximately 10,586 pounds of fentanyl were seized at the southern border in 2021, with US Customs and Border Patrol reporting a “substantial increase” in fentanyl seizures as of January.

Read the original article by clicking here.

Drugmaker Endo strikes $63 million opioid settlement with Texas

By Nate Raymond

(Reuters) -Endo International Plc has agreed to pay $63 million to resolve claims by the state of Texas and local governments that the drugmaker helped fuel the U.S. opioid epidemic, the state’s attorney general said on Thursday.

The deal announced by Texas Attorney General Ken Paxton marked the latest in a series of settlements that Endo has struck in recent months with state and local governments to resolve similar cases.

More than 3,400 lawsuits largely by state and local governments have been filed nationally accusing Endo of contributing to the drug abuse crisis by deceptively marketing pain medications including Opana ER, which it no longer sells.

“This settlement is a necessary step in the right direction, and we will continue to fight to heal our state from this devastating crisis,” Paxton said in a statement.

Endo did not immediately respond to a request for comment.

Thousands of lawsuits have been filed seeking to hold drugmakers, drug distributors and pharmacy chains responsible for a drug abuse crisis the U.S. government says has led to hundreds of thousands of overdose deaths over two decades.

Drug distributors McKesson Corp, AmerisourceBergen Corp and Cardinal Health Inc and the drugmaker Johnson & Johnson are pushing to finalize proposed settlements of up to $26 billion to resolve the cases against them.

Endo is not part of the proposed $26 billion deal, but previously agreed to settle lawsuits by states or counties in Alabama, Louisiana, New York, Ohio, Oklahoma and Tennessee for more than $136 million.

In November, a California judge following a trial found Endo and three other drugmakers not liable in a lawsuit by several large counties that accused them of fueling the opioid epidemic, saying they failed to prove their $50 billion case.

(Reporting by Nate Raymond in Boston; Editing by Mark Porter and Diane Craft)

New York, drug distributors reach $1.18 billion opioid settlement as national deal looms

By Brendan Pierson and Nate Raymond

NEW YORK (Reuters) -The three largest U.S. drug distributors agreed mid-trial to pay up to $1.18 billion to settle claims by New York state and two of its biggest counties over their role in the nationwide opioid epidemic, the state’s attorney general said on Tuesday.

McKesson Corp, Cardinal Health Inc and AmerisourceBergen Corp settled as state attorneys general prepare to announce as soon as this week a landmark $26 billion deal with the distributors and drugmaker Johnson & Johnson resolving cases nationwide.

The deal with New York Attorney General Letitia James and the populous Long Island counties of Nassau and Suffolk came three weeks into the first jury trial accusing companies of profiting from a flood of addictive painkillers that devastated communities.

“While no amount of money will ever compensate for the millions of addictions, the hundreds of thousands of deaths, or the countless communities decimated by opioids, this money will be vital in preventing any future devastation,” James said.

Hunter Shkolnik, a lawyer for Nassau County at the law firm Napoli Shkolnik, in a statement said that unlike the proposed national settlement, the New York deal “is not contingent on the rest of the country or other states joining.”

In a joint statement, the distributors called the settlement “an important step toward finalizing a broad settlement with states, counties, and political subdivisions.”

‘GETTING CLOSE’ ON NATIONAL SETTLEMENT

The national settlement is expected to be announced later this week, people familiar with the matter said. Joe Rice, a lead negotiator for lawyers for the cities and counties at Motley Rice, told reporters the parties are “getting close” to finalizing a deal.

After the framework is announced, states and their subdivisions will need to decide whether to join the global accord, the sources have said. The ultimate settlement price-tag could fluctuate depending on how many agree to the deal or reject it to pursue litigation on their own.

The settlement also calls the creation of a national clearinghouse of data on opioid shipments operated under the oversight of an independent third-party monitor.

Paul Geller, a lead negotiator for the plaintiffs at Robbins Geller Rudman & Dowd Geller, said that provision would be “transformative” in battling drug oversupply.

Nearly 500,000 people died from opioid overdoses in the United States from 1999 to 2019, according to the U.S. Centers for Disease Control and Prevention. The CDC last week said provisional data showed that 2020 was a record year for overall drug overdose deaths with 93,331, up 29% from a year earlier.

REMAINING DEFENDANTS

More than 3,300 cases have been filed largely by states and local governments alleging drugmakers falsely marketed opioid painkillers as safe, and distributors and pharmacies of ignoring red flags that they were being diverted to illegal channels.

The New York trial will continue against three drugmakers accused of deceptively marketing their painkillers – Endo International Plc, Teva Pharmaceutical Industries Ltd and AbbVie Inc’s Allergan unit.

Ahead of the trial, Johnson & Johnson agreed to pay $263 million to resolve the claims by the state and counties. Pharmacy operators Walgreens Boots Alliance Inc, CVS Health Corp, Rite Aid Corp and Walmart Inc agreed to settle with the counties for a combined $26 million.

Two other opioid cases are also on trial in West Virginia and California. The companies have denied wrongdoing.

James’ office said that of the nearly $1.18 billion the distributors agreed to pay, more than $1 billion will go toward addressing the epidemic. The counties have said the money will be used for mental health and addiction programs.

Payments will start in two months and will continue over the next 17 years, James said.

(Reporting by Brendan Pierson in New York and Nate Raymond in Boston; Editing by Tom Hals, Chizu Nomiyama, Bill Berkrot and Nick Zieminski)

U.S. and Mexico to set up joint team to fight drug cartels

FILE PHOTO: An agent of the office of the Attorney General of Mexico carries a package of seized marijuana at the site of a passageway Mexican authorities on Thursday attributed to the cartel of fugitive kingpin Joaquin "El Chapo" Guzman in Tijuana, October 24, 2015. REUTERS/Jorge Duenes/File Photo

By Karen Pierog

CHICAGO (Reuters) – The U.S. Drug Enforcement Administration and Mexico will set up a joint team in Chicago targeting Mexican drug cartels and their leaders and finances, to try to stem a flow of drugs that has led to a spike in U.S. overdose deaths, officials said on Wednesday.

DEA Chief of Operations Anthony Williams said at a joint news conference with Mexican government officials in Chicago that targeting cartel finances was key because “the sole purpose of these entities is one thing and one thing only – money.”

Mexico remains the principal highway for cocaine to the United States and has become the top source of heroin, which is fueling a surge in opioid addiction in the United States. It is also a major supplier of methamphetamines.

“It’s not just a Chicago problem, it’s a national problem. Actually, it’s an international problem,” Brian McKnight, special agent in charge of the DEA’s Chicago Field Division, said at the news conference.

Mexican President-elect Andres Manuel Lopez Obrador, a left-leaning nationalist, has vowed to shake up Mexico’s war on drug cartels after he takes power in December. He wants to rewrite the rules, aides have said, suggesting negotiated peace and amnesties rather than a hardline strategy that critics say has only perpetuated violence.

However, a change of direction without the United States could increase friction between the neighbors, who have been often at loggerheads since Donald Trump became U.S. president.

Trump has irked Mexico with demands that it pay for a border wall and his comments that it does nothing to slow illegal immigration. He has also pushed to revamp the North American Free Trade Agreement (NAFTA) to favor the United States.

But despite difference with the Trump administration on migration and trade issues, officials and security experts in the United States have applauded long-running bilateral efforts to crack down on drug gangs.

For the past 12 years, Mexico has fought the violent cartels by deploying thousands of police, soldiers, and intelligence officers.

(Reporting by Karen Pierog, Writing by Jon Herskovitz; Additional reporting by Dave Graham in Mexico City, Editing by Rosalba O’Brien)